A recent, retrospective cohort study of approximately 13,000 adults who were already using drug therapy for hypertension examined the effect of SGLT-2 inhibitors, primarily prescribed for the management of diabetes, on BP and the use of antihypertensive medication. Here, SLC5A2 is linked to diabetes mellitus.